Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LUMO
2022-501534-33-00Phase 4Authorised
- Sponsor
- University Medical Center Utrecht
- Start
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Unexplained infertility and infertility comparing Progesterone luteal phase support with Placebo luteal phase support (2 arms). Primary endpoint: Live birth within 6 months after randomization. Planned start Jan 2023; status: authorised.
02
Drugs
progesterone
03
Conditions
Unexplained infertilityinfertility
Beyond the preview
Go deeper on 2022-501534-33-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-501534-33-00.